PMC:7696151 / 41501-41772
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1176 | 169-189 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
1177 | 191-210 | Disease | denotes | lupus erythematosus | MESH:D008180 |
1178 | 220-238 | Disease | denotes | Sjögren’s syndrome | MESH:D012859 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T55 | 142-162 | Phenotype | denotes | auto-immune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
T56 | 169-189 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T269 | 0-271 | Sentence | denotes | Most of all, it showed immunosuppressive properties, allowing its employment (alone or in combination) in the first-line treatment of several auto-immune diseases, like rheumatoid arthritis, lupus erythematosus, primary Sjögren’s syndrome, and anti-phospholipid syndrome. |